| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |